|
2024-05-03 |
2024-05-02 |
PS
Planned sale
|
Bhatia Sangeeta N.
Non-Executive Director
|
1,000
-9.5%
402.95
100,000
USD
|
1,000
-9.5%
|
402.95
|
100,000
USD
|
|
|
2024-04-03 |
2024-04-02 |
PS
Planned sale
|
Ambrose Kristen
SVP & Chief Accounting Officer
Officer
|
240
-3.1%
419.00
100,560
USD
|
240
-3.1%
|
419.00
|
100,560
USD
|
|
|
2024-02-27 |
2024-02-26 |
PS
Planned sale
|
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Officer
|
883
-5.2%
425.70
375,893
USD
|
883
-5.2%
|
425.70
|
375,893
USD
|
|
|
2024-02-27 |
2024-02-26 |
PS
Planned sale
|
ALTSHULER DAVID
EVP, Global Research and CSO
Officer
|
4,239
-14.1%
425.70
1,804,542
USD
|
4,239
-14.1%
|
425.70
|
1,804,542
USD
|
|
|
2024-02-27 |
2024-02-26 |
PS
Planned sale
|
Sachdev Amit
EVP Chief Patient & Ext Af Off
Officer
|
3,004
-5.2%
425.70
1,278,803
USD
|
3,004
-5.2%
|
425.70
|
1,278,803
USD
|
|
|
2024-02-27 |
2024-02-26 |
PS
Planned sale
|
Ambrose Kristen
SVP & Chief Accounting Officer
Officer
|
883
-10.0%
425.70
375,893
USD
|
883
-10.0%
|
425.70
|
375,893
USD
|
|
|
2024-02-27 |
2024-02-26 |
PS
Planned sale
|
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Officer
|
354
-0.6%
425.70
150,698
USD
|
354
-0.6%
|
425.70
|
150,698
USD
|
|
|
2024-02-27 |
2024-02-26 |
PS
Planned sale
|
Arbuckle Stuart A
EVP, COO
Officer
|
5,034
-9.2%
425.70
2,142,974
USD
|
5,034
-9.2%
|
425.70
|
2,142,974
USD
|
|
|
2024-02-23 |
2024-02-21 |
PS
Planned sale
|
Sachdev Amit
EVP Chief Patient & Ext Af Off
Officer
|
3,191
-5.0%
421.77
1,345,868
USD
|
3,191
-5.0%
|
421.77
|
1,345,868
USD
|
|
|
2024-02-23 |
2024-02-21 |
PS
Planned sale
|
ALTSHULER DAVID
EVP, Global Research and CSO
Officer
|
3,002
-8.1%
421.77
1,266,154
USD
|
3,002
-8.1%
|
421.77
|
1,266,154
USD
|
|
|
2024-02-23 |
2024-02-21 |
PS
Planned sale
|
Arbuckle Stuart A
EVP, COO
Officer
|
3,603
-5.7%
421.77
1,519,637
USD
|
3,603
-5.7%
|
421.77
|
1,519,637
USD
|
|
|
2024-02-23 |
2024-02-21 |
PS
Planned sale
|
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Officer
|
1,201
-6.1%
421.77
506,546
USD
|
1,201
-6.1%
|
421.77
|
506,546
USD
|
|
|
2024-02-23 |
2024-02-21 |
PS
Planned sale
|
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Officer
|
360
-0.6%
421.77
151,837
USD
|
360
-0.6%
|
421.77
|
151,837
USD
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Officer
|
801
-3.9%
420.79
337,053
USD
|
801
-3.9%
|
420.79
|
337,053
USD
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
ALTSHULER DAVID
EVP, Global Research and CSO
Officer
|
4,002
-9.8%
420.79
1,684,002
USD
|
4,002
-9.8%
|
420.79
|
1,684,002
USD
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
Arbuckle Stuart A
EVP, COO
Officer
|
4,804
-7.1%
420.79
2,021,475
USD
|
4,804
-7.1%
|
420.79
|
2,021,475
USD
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
Sachdev Amit
EVP Chief Patient & Ext Af Off
Officer
|
4,254
-6.2%
420.79
1,790,041
USD
|
4,254
-6.2%
|
420.79
|
1,790,041
USD
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Officer
|
480
-0.8%
420.79
201,979
USD
|
480
-0.8%
|
420.79
|
201,979
USD
|
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
4,655
-20.6%
419.16
1,951,190
USD
|
4,655
-20.6%
|
419.16
|
1,951,190
USD
|
|
|
2024-02-16 |
2024-02-14 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
4,356
-16.2%
419.04
1,825,338
USD
|
4,356
-16.2%
|
419.04
|
1,825,338
USD
|
|
|
2024-02-14 |
2024-02-13 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
737
-2.7%
419.13
308,899
USD
|
737
-2.7%
|
419.13
|
308,899
USD
|
|
|
2024-02-14 |
2024-02-12 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
647
-2.3%
420.39
271,992
USD
|
647
-2.3%
|
420.39
|
271,992
USD
|
|
|
2024-02-14 |
2024-02-12 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
2,009
-6.6%
419.22
842,213
USD
|
2,009
-6.6%
|
419.22
|
842,213
USD
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Officer
|
913
-3.8%
420.24
383,679
USD
|
913
-3.8%
|
420.24
|
383,679
USD
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Biller Jonathan
EVP and Chief Legal Officer
Officer
|
1,738
-8.7%
418.77
727,822
USD
|
1,738
-8.7%
|
418.77
|
727,822
USD
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Sachdev Amit
EVP Chief Patient & Ext Af Off
Officer
|
3,222
-4.2%
420.24
1,354,013
USD
|
3,222
-4.2%
|
420.24
|
1,354,013
USD
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Arbuckle Stuart A
EVP, COO
Officer
|
4,295
-5.4%
420.24
1,804,931
USD
|
4,295
-5.4%
|
420.24
|
1,804,931
USD
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
ALTSHULER DAVID
EVP, Global Research and CSO
Officer
|
3,145
-6.2%
420.24
1,321,655
USD
|
3,145
-6.2%
|
420.24
|
1,321,655
USD
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Ambrose Kristen
SVP & Chief Accounting Officer
Officer
|
1,374
-12.4%
420.24
577,410
USD
|
1,374
-12.4%
|
420.24
|
577,410
USD
|
|
|
2024-02-13 |
2024-02-12 |
PS
Planned sale
|
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Officer
|
314
-0.5%
420.24
131,955
USD
|
314
-0.5%
|
420.24
|
131,955
USD
|
|
|
2024-01-10 |
2024-01-08 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
6,648
-73.3%
419.07
2,785,977
USD
|
6,648
-73.3%
|
419.07
|
2,785,977
USD
|
|
|
2024-01-04 |
2024-01-02 |
PS
Planned sale
|
WAGNER CHARLES F JR
EVP & Chief Financial Officer
Officer
|
3,000
-6.4%
405.00
1,215,000
USD
|
3,000
-6.4%
|
405.00
|
1,215,000
USD
|
|
|
2023-12-19 |
2023-12-15 |
PS
Planned sale
|
Kewalramani Reshma
CEO & President
Executive Director
|
17,135
-13.6%
407.00
6,973,945
USD
|
17,135
-13.6%
|
407.00
|
6,973,945
USD
|
|
|
2023-12-15 |
2023-12-13 |
PS
Planned sale
|
Arbuckle Stuart A
EVP, COO
Officer
|
8,603
-13.2%
399.00
3,432,597
USD
|
8,603
-13.2%
|
399.00
|
3,432,597
USD
|
|
|
2023-12-15 |
2023-12-13 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
100
-1.1%
400.19
40,019
USD
|
100
-1.1%
|
400.19
|
40,019
USD
|
|
|
2023-12-15 |
2023-12-13 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
13,254
-59.1%
399.41
5,293,780
USD
|
13,254
-59.1%
|
399.41
|
5,293,780
USD
|
|
|
2023-12-15 |
2023-12-13 |
PS
Planned sale
|
Kewalramani Reshma
CEO & President
Executive Director
|
5,098
-4.5%
397.00
2,023,906
USD
|
5,098
-4.5%
|
397.00
|
2,023,906
USD
|
|
|
2023-11-21 |
2023-11-20 |
PS
Planned sale
|
WAGNER CHARLES F JR
EVP & Chief Financial Officer
Officer
|
3,000
-6.0%
349.88
1,049,640
USD
|
3,000
-6.0%
|
349.88
|
1,049,640
USD
|
|
|
2023-11-17 |
2023-11-15 |
PS
Planned sale
|
Sachdev Amit
EVP Chief Patient & Ext Af Off
Officer
|
35
-0.1%
369.92
12,947
USD
|
35
-0.1%
|
369.92
|
12,947
USD
|
|
|
2023-11-17 |
2023-11-15 |
PS
Planned sale
|
ALTSHULER DAVID
EVP, Global Research and CSO
Officer
|
19
-0.1%
369.92
7,028
USD
|
19
-0.1%
|
369.92
|
7,028
USD
|
|
|
2023-11-16 |
2023-11-14 |
PS
Planned sale
|
Bozic Carmen
EVP and CMO
Officer
|
5,650
-16.2%
380.82
2,151,633
USD
|
5,650
-16.2%
|
380.82
|
2,151,633
USD
|
|
|
2023-11-15 |
2023-11-13 |
PS
Planned sale
|
Kewalramani Reshma
CEO & President
Executive Director
|
5,097
-4.3%
377.00
1,921,569
USD
|
5,097
-4.3%
|
377.00
|
1,921,569
USD
|
|
|
2023-11-08 |
2023-11-06 |
PS
Planned sale
|
SACHS BRUCE I
Non-Executive Director
|
11,250
-22.0%
385.00
4,331,250
USD
|
11,250
-22.0%
|
385.00
|
4,331,250
USD
|
|
|
2023-11-02 |
2023-10-31 |
PS
Planned sale
|
Bozic Carmen
EVP and CMO
Officer
|
5,651
-13.9%
355.92
2,011,304
USD
|
5,651
-13.9%
|
355.92
|
2,011,304
USD
|
|
|
2023-10-19 |
2023-10-17 |
PS
Planned sale
|
Bozic Carmen
EVP and CMO
Officer
|
5,651
-12.2%
373.25
2,109,236
USD
|
5,651
-12.2%
|
373.25
|
2,109,236
USD
|
|
|
2023-10-19 |
2023-10-17 |
PS
Planned sale
|
Bhatia Sangeeta N.
Non-Executive Director
|
243
-5.9%
375.00
91,125
USD
|
243
-5.9%
|
375.00
|
91,125
USD
|
|
|
2023-10-18 |
2023-10-16 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
12,962
-36.6%
374.00
4,847,788
USD
|
12,962
-36.6%
|
374.00
|
4,847,788
USD
|
|
|
2023-10-11 |
2023-10-06 |
PS
Planned sale
|
Bhatia Sangeeta N.
Non-Executive Director
|
242
-5.5%
360.00
87,120
USD
|
242
-5.5%
|
360.00
|
87,120
USD
|
|
|
2023-10-05 |
2023-10-03 |
PS
Planned sale
|
Bozic Carmen
EVP and CMO
Officer
|
5,651
-10.9%
345.28
1,951,177
USD
|
5,651
-10.9%
|
345.28
|
1,951,177
USD
|
|
|
2023-10-03 |
2023-10-02 |
PS
Planned sale
|
Biller Jonathan
EVP and Chief Legal Officer
Officer
|
610
-5.5%
346.76
211,524
USD
|
610
-5.5%
|
346.76
|
211,524
USD
|
|
|
2023-09-21 |
2023-09-19 |
PS
Planned sale
|
Bozic Carmen
EVP and CMO
Officer
|
5,651
-9.8%
351.00
1,983,501
USD
|
5,651
-9.8%
|
351.00
|
1,983,501
USD
|
|
|
2023-09-07 |
2023-09-05 |
PS
Planned sale
|
Bozic Carmen
EVP and CMO
Officer
|
5,651
-8.9%
352.66
1,992,882
USD
|
5,651
-8.9%
|
352.66
|
1,992,882
USD
|
|
|
2023-08-25 |
2023-08-23 |
PS
Planned sale
|
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Officer
|
2,500
-4.9%
355.00
887,500
USD
|
2,500
-4.9%
|
355.00
|
887,500
USD
|
|
|
2023-08-14 |
2023-08-10 |
PS
Planned sale
|
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Officer
|
5,750
-10.1%
345.79
1,988,293
USD
|
5,750
-10.1%
|
345.79
|
1,988,293
USD
|
|
|
2023-08-14 |
2023-08-10 |
PS
Planned sale
|
Kearney Terrence C
Non-Executive Director
|
10,000
-60.5%
350.00
3,500,000
USD
|
10,000
-60.5%
|
350.00
|
3,500,000
USD
|
|
|
2023-08-14 |
2023-08-10 |
PS
Planned sale
|
Sachdev Amit
EVP, Chief Patient Officer
Officer
|
10,031
-14.6%
350.00
3,510,850
USD
|
10,031
-14.6%
|
350.00
|
3,510,850
USD
|
|
|
2023-08-11 |
2023-08-09 |
PS
Planned sale
|
ALTSHULER DAVID
EVP, Global Research and CSO
Officer
|
63
-0.2%
345.51
21,767
USD
|
63
-0.2%
|
345.51
|
21,767
USD
|
|
|
2023-08-11 |
2023-08-09 |
PS
Planned sale
|
Bhatia Sangeeta N.
Non-Executive Director
|
242
-5.2%
345.51
83,613
USD
|
242
-5.2%
|
345.51
|
83,613
USD
|
|
|
2023-07-18 |
2023-07-17 |
PS
Planned sale
|
Kewalramani Reshma
CEO & President
Executive Director
|
7,828
-6.2%
355.00
2,778,940
USD
|
7,828
-6.2%
|
355.00
|
2,778,940
USD
|
|
|
2023-07-18 |
2023-07-17 |
PS
Planned sale
|
SACHS BRUCE I
Non-Executive Director
|
3,842
-8.8%
357.29
1,372,708
USD
|
3,842
-8.8%
|
357.29
|
1,372,708
USD
|
|
|
2023-07-18 |
2023-07-17 |
PS
Planned sale
|
SACHS BRUCE I
Non-Executive Director
|
5,711
-11.5%
356.75
2,037,399
USD
|
5,711
-11.5%
|
356.75
|
2,037,399
USD
|
|
|
2023-07-18 |
2023-07-17 |
PS
Planned sale
|
SACHS BRUCE I
Non-Executive Director
|
1,697
-3.3%
355.54
603,351
USD
|
1,697
-3.3%
|
355.54
|
603,351
USD
|
|
|
2023-06-20 |
2023-06-15 |
PS
Planned sale
|
Arbuckle Stuart A
EVP, COO
Officer
|
8,603
-13.2%
349.00
3,002,447
USD
|
8,603
-13.2%
|
349.00
|
3,002,447
USD
|
|
|
2023-06-01 |
2023-05-30 |
PS
Planned sale
|
Ambrose Kristen
SVP & Chief Accounting Officer
Officer
|
289
-4.1%
329.82
95,318
USD
|
289
-4.1%
|
329.82
|
95,318
USD
|
|
|
2023-06-01 |
2023-05-30 |
PS
Planned sale
|
Arbuckle Stuart A
EVP, COO
Officer
|
82
-0.1%
329.82
27,045
USD
|
82
-0.1%
|
329.82
|
27,045
USD
|
|
|
2023-05-09 |
2023-05-08 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
1,125
-3.1%
349.00
392,625
USD
|
1,125
-3.1%
|
349.00
|
392,625
USD
|
|
|
2023-05-09 |
2023-05-08 |
PS
Planned sale
|
Sanna Bastiano
EVP, Cell & Genetic Therapies
Officer
|
2,850
-8.2%
350.00
997,500
USD
|
2,850
-8.2%
|
350.00
|
997,500
USD
|
|
|
2023-05-09 |
2023-05-05 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
171
-0.5%
350.30
59,901
USD
|
171
-0.5%
|
350.30
|
59,901
USD
|
|
|
2023-05-09 |
2023-05-05 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
708
-1.9%
349.38
247,361
USD
|
708
-1.9%
|
349.38
|
247,361
USD
|
|
|
2023-05-09 |
2023-05-05 |
PS
Planned sale
|
Sanna Bastiano
EVP, Cell & Genetic Therapies
Officer
|
422
-1.2%
350.03
147,713
USD
|
422
-1.2%
|
350.03
|
147,713
USD
|
|
|
2023-05-04 |
2023-05-03 |
PS
Planned sale
|
Sanna Bastiano
EVP, Cell & Genetic Therapies
Officer
|
728
-2.0%
351.60
255,965
USD
|
728
-2.0%
|
351.60
|
255,965
USD
|
|
|
2023-05-04 |
2023-05-03 |
PS
Planned sale
|
Sanna Bastiano
EVP, Cell & Genetic Therapies
Officer
|
2,053
-5.4%
350.44
719,453
USD
|
2,053
-5.4%
|
350.44
|
719,453
USD
|
|
|
2023-05-04 |
2023-05-03 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
700
-1.8%
351.59
246,113
USD
|
700
-1.8%
|
351.59
|
246,113
USD
|
|
|
2023-05-04 |
2023-05-03 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
1,800
-4.5%
350.53
630,954
USD
|
1,800
-4.5%
|
350.53
|
630,954
USD
|
|
|
2023-05-04 |
2023-05-03 |
PS
Planned sale
|
LEIDEN JEFFREY M
Executive Chairman
Executive Director
|
2,008
-4.8%
349.22
701,234
USD
|
2,008
-4.8%
|
349.22
|
701,234
USD
|
|
